NCT Number: NCT00366496
Surgical Outcomes After Routine Cataract Extraction & Implantation of a Conventional or Spheric Intraocular Lens
To determine quality of vision post cataract extraction and intraocular lens (IOL) implantation of 2 different acrylic intraocular lenses: Acrysof® Single-Piece IOL and Acrysof® WF, through evaluation of contrast sensitivity, glare testing, visual outcomes, wavefront, corneal topography, and patient satisfaction.
Looking for future studies?
Notify MeKey information
Conditions
Age range
50 year–80 year
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Unilateral or bilateral cataract
- Eligible for phacoemulsification with primary implantation of a posterior chamber IOL. If bilateral, patient will receive the same IOL than the fellow eye.
- Expected maximum of 4 weeks and minimum of 1 week interval between primary and second eye surgeries when bilateral.
- Best corrected visual acuity (BCVA) should be no better than 20/40 in the presence of a glare source using Snellen visual acuity. In the Snellen visual acuity chart, better than 20/40 will be at least 3 letters read correctly in the 20/30 line.
- Naturally dilated pupil (in dim light) ≥ 4.0 mm in both eyes.
Exclusion criteria
- Preoperative ocular pathology potentially affecting visual acuity
- Previous intraocular or corneal surgery.
- Keratometric astigmatism exceeding 1.5 diopters.
- Planned postoperative refraction for mono-vision.
- Current contact lens usage.
- Other ocular surgery at the time of the cataract extraction.
- Uncontrolled diabetes.
- Any neurological condition that might interfere with performance of required test.
- Auto-immune deficiency disease.
- Other severe acute or chronic medical or psychiatric condition that may increase the risk associated with study participation or study device implantation or may interfere with the interpretation of study results.
- Use of any systemic or topical drug known to interfere with visual performance.
Surgical Exclusion Criteria
- Significant anterior chamber bleeding.
- Detached Descemet's membrane
- Iris damage
- Posterior capsule rupture
- Radial tear in capsulorhexis
- Vitreous loss
- Zonular rupture.
- Use of corneal sutures for more than 1 week.
Post-implantation Exclusion Criteria
- Haptic not in the capsular bag.
- Descentration of the IOL of more than 1.0 mm
- Ocular pathologies potentially affecting visual acuity that were not evident prior to surgery.
Treatment and study plan
Acrysof IQ (SN60WF)
DevicePrimary outcomes
-
Contrast sensitivity
-
Visual acuity
Secondary outcomes
-
Induction of hight order aberrations
-
Corneal topography
-
Patient satisfaction
Sponsors and collaborators
Lead sponsor
Medical University of South Carolina
Other
Registry information
Official study title
Comparison of Visual Outcomes, Wavefront Analysis, Contrast Sensitivity and Glare Testing Following Cataract Extraction Between Acrysof Single-Piece IOL and Acrysof WF
Important dates
- Study start
- 2004
- Study completion
- 2005
- First posted
- Aug 21, 2006
- Registry last updated
- Aug 21, 2006
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Cerebral Oxymeter and End Tidal Carbondioxide Values Under Surgical Drapes With and Without Past COVID-19 Infection
NCT05571683
Anesthesia, Local, Cataract Extraction
Düzce, Turkey (Türkiye)
View Trial DetailsA Study Comparing Two Monofocal, Aspheric, Hydrophobic Acrylic Intraocular Lenses: the Alcon CLAREON® and the Abbott Medical Optics PCB00
NCT03364972
Behavior, Cataract
London, United Kingdom
View Trial DetailsClinical Study to Evaluate the Efficacy and Tolerability of an Anti-inflammatory/Antibiotic Treatment Following Ocular Cataract Extraction
NCT02973880
Cataract, Cataract Extraction
Potsdam, Germany
View Trial DetailsComparison of Acular LS With Lotemax to Prevent Inflammation After Cataract Surgery and Intraocular Lens Implantation
NCT00366691
Cataract, Cataract Extraction
Charleston, South Carolina, United States
View Trial Details